News About: R&D
SK Chemicals will jointly carry out development and Phase 3 clinical trial of next generation children enteritis vaccine
SK Chemicals is enlarging its position in the international market with its technology and manufacturing power in vaccine.
SK Chemicals announced on the 1st that it signed an agreement for development of a next-gener...
Korea conducts 2nd largest number of clinical trials for stem cell treatments in the world
It was observed Korea became a country that conducted the 2nd highest number of clinical trials for stem cell treatments after the U.S.
The Ministry of Food and Drug Safety’s National Institute of Food and Drug Safet...
Oscotec’s FDA-approved clinical trials for treatment of acute myeloid leukemia
Oscotec(CEO Jung-Geun Kim), a new drug development company, announced on the 13th that it made an agreement since the U.S. Phase 1 clinical trial project of the next-generation new drug candidate(SKI-G-801) for the tr...
What will be the answers for future new drug development?
What will be the answers for future new drug development?
Celgene chose ‘innovation followed by continuous efforts on new drug development’ and ‘active cooperation with various partners.’
In the lecture about ‘Chang...
Korea advanced in global clinical trials, showing 3.41% market share last year
The number of clinical trials is decreasing, but the Korean clinical trial’s market share in the global market was actually increased by approx. 10% to 3.42%. There were changes in ranking as well because of the China...
R&D chiefs from Korean and overseas pharmas will illustrate present and future of ‘open innovation’
The Korea’s largest ‘Open Innovation’ stage will open for the pharmaceutical industry.
The Korea Pharmaceutical and Bio-Pharma Manufacturers Association(Chairman Hee-Mok Won) and the Korean Research-based Pharmaceuti...
Bloody competition among bioequivalence test service organizations causes shutdown of business
Due to fierce competition among service organizations for bioequivalence test, one of them decided to shut down business.
Korea Pharmaceutical Test & Research Institute, an agency of the Korea Pharmaceutical Traders ...
Pharmas hesitated in developing generics, showing decrease in bioequivalently-tested drugs
It was observed there were only 96 pharmaceutical products approved through bioequivalence test this year. This is because pharmaceutical companies are hesitated in developing generic products.
According to the Minis...
Development of generics focusing on metabolism, cardiovascular system and central nervous system
The National Institute of Food and Drug Safety Evaluation(NIFDS) at Ministry of Food and Drug Safety announced the number of generic products approved was similar to the last year even though the number of approvals o...
Pharmas continue this R&D this year too
New drug development will continue.
Major Korean pharmaceutical companies have a plan to export new drug pipelines and commercialize them. In order to export, transfer and commercialize technology, they have more act...
Which are outstanding tetravalent vaccines even for the young?
Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer
Who will be the next Pharmaceutical Safety Bureau Director?
Celltrion completes clinical trials for Remsima SC for European approval
Sales listed pharmas made in the first half of the year
April
January
February
March
April
May
June
July
August
September
October
November
December
2025
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
|---|---|---|---|---|---|---|
30 | 31 | 1 | 2 | 3 | 4 | 5 |
6 | 7 | 8 | 9 | 10 | 11 | 12 |
13 | 14 | 15 | 16 | 17 | 18 | 19 |
20 | 21 | 22 | 23 | 24 | 25 | 26 |
27 | 28 | 29 | 30 | 1 | 2 | 3 |
00:00
01:00
02:00
03:00
04:00
05:00
06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
22:00
23:00
